Recent Status of Probiotics in the Prevention and Treatment of Hyperuricemia (HUA)

Authors

  • Tongyu Chen
  • Sibo Qiu

DOI:

https://doi.org/10.61173/b12jbx75

Keywords:

probiotics, uric acid, List the Hyperuricemia

Abstract

A metabolic condition called hyperuricemia (HUA) is intimately linked to the beginning and development of numerous chronic illnesses. Increased blood levels of uric acid (UA), or hyperuricemia, are indicative of a higher risk of developing gout and other metabolic problems. Probiotics have been shown to have positive impacts on human health regulation in recent years. These effects include a significant contribution to the control of conditions including type 2 diabetes, obesity, hypertension, and human immunity. Furthermore, pertinent research conducted in the last several years has discovered that probiotics can somewhat alleviate HUA. The use of probiotics for the prevention and treatment of hyperuricemia is discussed in this paper along with the current status of research in this area. Probiotics work by modulating urate metabolism, attenuating inflammatory responses, and improving related metabolic parameters. Additionally, clinical trials assessing the efficacy of specific probiotic strains or blends in reducing serum UA concentrations are included in the analysis, indicating that probiotics could be a future focus for the prevention of hyperuricemia. However, the optimal dose and duration of probiotic supplementation remains to be determined and clinical trials on human subjects should be further expanded. To ascertain the long-term safety and effectiveness of probiotics as an adjuvant treatment for HUA and associated comorbidities, more research is required.

References

explore the gut microbiome. However, the quality of DNA 2019,46(3):135-136. extraction may be impacted by differences in fecal consis- [2] Yang Xiru, Tang Jiayue, Zeng Xiaoqun, et al. Probiotics tency and the presence of microbial contaminants, which for relieving hyperuricemia: current status, mechanism of could then have an impact on how sample α-diversity is action and challenges [J]. Science and Technology of Food interpreted [29]. Industry,20241-11. While probiotics have shown promising effects in regulat- [3] Ma Hongmei. Progress in pathogenesis and drug therapy ing UA levels in in vitro simulation studies, there is a rel- of hyperuricemia [J]. Chinese Journal of Urban and Rural

ative paucity of in vivo research and clinical application Enterprise Health, 2019,36(9):22-24. studies. The effects of probiotics in people still need to be [4] Xu Dongbo, Chi Yan, Wang Lina, et al. Research progress of confirmed by clinical trials because in vitro trials might integrated Chinese and Western medicine nursing hyperuricemia

not accurately mimic the intricate physiological and met- [J]. Guangming Chinese Medicine, 2019,39(3):629-632. abolic systems found in the body. Furthermore, studies on [5] Niu Chunhua, Xiao Ruxue, Zhao Zijian, et al. Effect of the application of probiotics to treat HUA are still in their Lactobacillus plantarum UA149 on lowering uric acid [J].

infancy, and the underlying mechanisms are still unclear. Modern Food Science and Technology, 2020, 36(2):7. Different probiotics may operate through different mech- [6] Ni Caixin. Effect of Lactobacillus on hyperuricemia and its anisms, and whether other potential mechanisms exist pathway [D]. Jiangnan University,2021 remains uncertain. The antibiotic resistance and safety of [7] Singh D, Kumar V, Singh C. IFN-γ regulates xanthine probiotics have also not been comprehensively studied. oxidase-mediated iNOS-independent oxidative stress in maneb- Thus, more thorough investigation and copious data are and paraquat-treated rat polymorphonuclear leukocytes. Mol required to gain a deeper comprehension of the function Cell Biochem. 2017 Mar;427(1-2):133-143. of probiotics in the management of HUA. [8] Ishii Y, Sugimoto S, Izawa N, Sone T, Chiba K, Miyazaki K. Oral administration of Bifidobacterium breve attenuates UV- induced barrier perturbation and oxidative stress in hairless mice 7. Conclusion skin. Arch Dermatol Res. 2014 Jul;306(5):467-73. The epidemiological characteristics of HUA indicate it‘s a [9] Jung Lee J, Han Yoon J, Jin Kim S, Soo Yoo H, Jong Chung health issue that demands concentrated consideration. Pro- S, Hyun Lee Y, Yun Kang S, Shin HW, Keun Song S, Yong biotics, serving as a harmless and efficacious supplemen- Hong J, Sunwoo M, Eun Lee J, Sam Baik J, Sohn YH, Hyu Lee tary treatment, have demonstrated encouraging uses in P. Inosine 5’-Monophosphate to Raise Serum Uric Acid Level both preventing and curing HUA. Probiotics, by maintain- in Multiple System Atrophy (IMPROVE-MSA study). Clin Dean&Francis ISSN 2959-409X Pharmacol Ther. 2021 May;109(5):1274-1281. 6;13:940228. [10] Yamada N, Saito-Iwamoto C, Nakamura M, Soeda M, [20] Cao J, Wang T, Liu Y, Zhou W, Hao H, Liu Q, Yin B, Yi H. Chiba Y, Kano H, Asami Y. Lactobacillus gasseri PA-3 Uses Lactobacillus fermentum F40-4 ameliorates hyperuricemia by the Purines IMP, Inosine and Hypoxanthine and Reduces their modulating the gut microbiota and alleviating inflammation in Absorption in Rats. Microorganisms. 2017 Mar 8;5(1):10. mice. Food Funct. 2023 Apr 3;14(7):3259-3268. [11] Yamanaka H, Taniguchi A, Tsuboi H, Kano H, Asami Y. [21] Kelly DM, Kelleher EM, Sood MM. Stroke and Chronic Hypouricaemic effects of yoghurt containing Lactobacillus Kidney Disease. Contrib Nephrol. 2021;199:80-90. gasseri PA-3 in patients with hyperuricaemia and/or gout: [22] Wu Y, Ye Z, Feng P, Li R, Chen X, Tian X, Han R, Kakade A, A randomised, double-blind, placebo-controlled study. Mod Liu P, Li X. Limosilactobacillus fermentum JL-3 isolated from Rheumatol. 2019 Jan;29(1):146-150. “Jiangshui” ameliorates hyperuricemia by degrading uric acid. [12] Kuo YW, Hsieh SH, Chen JF, Liu CR, Chen CW, Huang Gut Microbes. 2021 Jan-Dec;13(1):1-18. YF, Ho HH. Lactobacillus reuteri TSR332 and Lactobacillus [23] Handayani I, Utami T, Hidayat C, et al. Screening of fermentum TSF331 stabilize serum uric acid levels and prevent lactic acid bacteria producing uricase and stability assessment hyperuricemia in rats. PeerJ. 2021 May 3;9:e11209. in simulated gastrointestinal conditions[J]. International Food [13] Li M, Wu X, Guo Z, Gao R, Ni Z, Cui H, Zong M, Van Research Journal, 2018, 25(4): 1661-1667. Bockstaele F, Lou W. Lactiplantibacillus plantarum enables [24] Ge H, Jiang Z, Li B, Xu P, Wu H, He X, Xu W, Huang blood urate control in mice through degradation of nucleosides Z, Xiong T, Wang P, Lv G, Chen S. Dendrobium officinalis in gastrointestinal tract. Microbiome. 2023 Jul 19;11(1):153. Six Nostrum Promotes Intestinal Urate Underexcretion via [14] Steinert RE, Lee YK, Sybesma W. Vitamins for the Gut Regulations of Urate Transporter Proteins in Hyperuricemic Microbiome. Trends Mol Med. 2020 Feb;26(2):137-140. doi: Rats. Comb Chem High Throughput Screen. 2023;26(4):848- 10.1016/j.molmed.2019.11.005. Epub 2019 Dec 17. PMID: 861. 31862244. [25] Lee Y, Werlinger P, Suh JW, Cheng J. Potential Probiotic [15] Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate Lacticaseibacillus paracasei MJM60396 Prevents Hyperuricemia the hydrogen peroxide-induced epithelial barrier disruption by in a Multiple Way by Absorbing Purine, Suppressing a PKC- and MAP kinase-dependent mechanism. Am J Physiol Xanthine Oxidase and Regulating Urate Excretion in Mice. Gastrointest Liver Physiol. 2008 Apr;294(4):G1060-9. Microorganisms. 2022 Apr 20;10(5):851. [16] Zhang L, Liu J, Jin T, Qin N, Ren X, Xia X. Live and [26] Ahire JJ, Rohilla A, Kumar V, Tiwari A. Quality pasteurized Akkermansia muciniphila attenuate hyperuricemia Management of Probiotics: Ensuring Safety and Maximizing in mice through modulating uric acid metabolism, inflammation, Health Benefits. Curr Microbiol. 2023 Nov 8;81(1):1. and gut microbiota. Food Funct. 2022 Nov 28;13(23):12412- [27] Roe AL, Boyte ME, Elkins CA, Goldman VS, Heimbach 12425. J, Madden E, Oketch-Rabah H, Sanders ME, Sirois J, Smith [17] Deng Ying, He Chunyang, Tang Yan, et al. Effect and A. Considerations for determining safety of probiotics: A USP mechanism of Lactobacillus brevis DM9218 on hyperuricemia perspective. Regul Toxicol Pharmacol. 2022 Dec;136:105266. induced by high fructose diet in mice [J]. Chinese Journal of [28] Pace F, Macchini F, Massimo Castagna V. Safety of

Microecology, 2017, 29(12):4. probiotics in humans: A dark side revealed? Dig Liver Dis. 2020 [18] Shao T, Shao L, Li H, Xie Z, He Z, Wen C. Combined Sep;52(9):981-985. Signature of the Fecal Microbiome and Metabolome in Patients [29] Yang F, Sun J, Luo H, Ren H, Zhou H, Lin Y, Han M, with Gout. Front Microbiol. 2017 Feb 21;8:268. Chen B, Liao H, Brix S, Li J, Yang H, Kristiansen K, Zhong H. [19] Cao J, Liu Q, Hao H, Bu Y, Tian X, Wang T, Yi H. Assessment of fecal DNA extraction protocols for metagenomic Lactobacillus paracasei X11 Ameliorates Hyperuricemia and studies. Gigascience. 2020 Jul 1;9(7):giaa071. Modulates Gut Microbiota in Mice. Front Immunol. 2022 Jul

Downloads

Published

2025-06-26